Table 4. Underlying malignancies present in patients with diagnostic features of a DIC.
| Primary diagnosis | Staging (Solid organ malignancies) |
World Health organisation subtyping (Haematological malignancies) |
HIV status | Total | ||
|---|---|---|---|---|---|---|
| Number of patients | ||||||
| Negative | Positive | Unknown | ||||
| Haematological Malignancies | ||||||
| Myelodysplastic syndrome | Myelodysplastic syndrome with excess blasts | 2 | 2 | |||
| Acute myeloid leukaemia (AML) | AML with recurrent translocation t(15;17) n = 5 AML with recurrent translocation t(8;21) n = 3 AML NOS, Acute monoblastic n = 1 AML not otherwise specified n = 6 |
4 | 7 | 4 | 15 | |
| Chronic Myeloid leukaemia | CML with BCR-ABL1 | - | - | 2 | 2 | |
| B-cell Acute Lymphoblastic leukaemia (ALL) | B-cell ALL, not otherwise specified n = 2 | 1 | - | 1 | 2 | |
| Acute leukaemia | Not subtyped | 2 | - | 1 | 3 | |
| Diffuse Large | Gastric (n = 1), Plasmablastic (n = 1), NOS (n = 1) | - | 2 | 1 | 3 | |
| B-cell lymphoma | ||||||
| B-cell Lymphoproliferative disorder | Not subtyped | - | 1 | - | 1 | |
| Hairy cell leukaemia | Hairy cell leukaemia | 1 | - | 1 | 2 | |
| Castleman’s Disease | Castleman’s Disease | 1 | - | - | 1 | |
| Monoclonal gammopathy of uncertain significance | 1 | - | - | 1 | ||
| Hodgkin Lymphoma | Classical (n = 1), Nodular sclerosing HL (n = 1) HL NOS (n = 1) |
- | 3 | - | 3 | |
| Plasma cell myeloma | 1 | 1 | - | 2 | ||
| Solid Organ Malignancies | ||||||
| Adenocarcinoma | ||||||
| Breast Ductal | Stage 4 | - | - | 1 | 1 | |
| Ovarian | Stage 4 | - | 1 | 1 | 2 | |
| Prostatic | Stage 4 | 1 | - | 1 | 2 | |
| Squamous carcinoma | ||||||
| Cervical | Stage 1 (1) Stage 2b (1) Stage 4 (3) |
1 | 3 | 1 | 5 | |
| Oesophagus | Stage 4 | - | 1 | - | 1 | |
| No identifiable primary | Stage 4 | - | - | 2 | 2 | |
| Sarcoma | ||||||
| Kaposi Sarcoma | Stage 4 | - | 1 | - | 1 | |